ClinConnect ClinConnect Logo
Search / Trial NCT06874439

An Evaluation of the WHO QUAlityRights Program

Launched by GCS-CCOMS · Mar 7, 2025

Trial Information

Current as of May 09, 2025

Active, not recruiting

Keywords

User Rights Recovery Oriented Practices Mental Health Settings Satisfaction With Care Interventional Study Randomized Controlled Trial

ClinConnect Summary

This clinical trial is looking at the World Health Organization's QualityRights (QR) program, which aims to enhance mental health care by ensuring that facilities respect the rights and needs of their patients. The study will explore whether this program makes people feel more satisfied with their mental health care. Researchers will compare the experiences of patients receiving care under the QR program with those receiving standard care practices.

To participate in this study, you need to be an adult aged 18 or older and have been hospitalized in a psychiatric unit for at least three days. You also need to agree to join the study. Mental health professionals who have been working in the field for at least three months can also participate. However, individuals who cannot participate due to physical or mental health issues, those under legal protection, or those who do not speak or understand French will not be included. If you join, you can expect to share your experiences with mental health care, which will help researchers understand how to improve services for everyone.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults (18 years or older)
  • Persons having formulated a non-opposition to participate in the study
  • Population a (users): Service users of the psychiatric sectors involved in the study hospitalized full-time since at least 3 days in an inpatient unit.
  • Population b (professionals): Mental health professionals working in the sector since at least 3 months at the time of study participation
  • Exclusion Criteria:
  • Persons physically or psychologically unable to participate at the time of the study
  • Persons subject to a safeguard of justice measure
  • Persons who do not speak or understand the French language

About Gcs Ccoms

GCS-CCOMS is a leading clinical trial sponsor dedicated to advancing innovative therapies through rigorous research and development. With a strong commitment to enhancing patient outcomes, the organization specializes in the design, implementation, and management of clinical trials across various therapeutic areas. GCS-CCOMS collaborates with academic institutions, healthcare providers, and pharmaceutical companies to ensure the highest standards of scientific integrity and regulatory compliance. Through a patient-centered approach and a focus on ethical practices, GCS-CCOMS strives to contribute to the advancement of medical knowledge and improve the quality of care available to patients worldwide.

Locations

Armentières, , France

Armentières, , France

Erstein, , France

Laxou, , France

Montéléger, , France

Nanterre, , France

Nice, , France

Plaisir, , France

Plaisir, , France

Pont Du Casse, , France

Patients applied

0 patients applied

Trial Officials

Déborah Sebbane, MD, PhD

Study Chair

GCS-CCOMS & ECEVE 1123 INSERM

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported